Page last updated: 2024-11-05

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Fungemia

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Fungemia in 2 studies

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source

Fungemia: The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Villar-Vidal, M1
Marcos-Arias, C1
Eraso, E1
Quindós, G1
Pulcrano, G1
Panellis, D1
De Domenico, G1
Rossano, F1
Catania, MR1

Other Studies

2 other studies available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Fungemia

ArticleYear
Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis.
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:9

    Topics: Aerobiosis; Biofilms; Candida; Candida albicans; Candidiasis; Candidiasis, Oral; Fungemia; Humans; O

2011
Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
    FEMS yeast research, 2012, Volume: 12, Issue:4

    Topics: Ambroxol; Antifungal Agents; Biofilms; Candida; Colorimetry; Drug Synergism; Fungemia; Humans; Micro

2012